Waiver of equivalence tests for some ingredients eyed

Published: 2002-06-17 06:59:00

Updated: 2002-06-17 06:59:00

The Korea Food and Drug Administration (KFDA) says it has recently drafted a guideline to waiver the bioeqivalence tests on some ingredients used for liquid-form preparations (such as syrups), digestive enzymes, injectable preparations, eye drops, ear drops, topical preparations, ointments, cream...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK